Innovatus Life Sciences Acquisition Corp. Watch

from S-1/A 14 pages Form of Indemnity Agreement

from S-1/A 7 pages Innovatus Life Sciences Acquisition Corp., a Delaware Corporation (The “Company”, “We” or “US”), Is Pleased to Accept the Offer Made by Innovatus Life Sciences Acquisition Sponsor, LLC, a Delaware Limited Liability Company (“Subscriber” or “You”), to Purchase 585,000 Shares (Or 637,500 Shares if the Over-Allotment Option in Connection With the Ipo (As Defined Below) Is Exercised in Full) (The “Shares”) of Class a Common Stock of the Company, $0.0001 Par Value Per Share (“Class a Common Stock”), at a Price of $10.00 Per Share Concurrently With the Company’s Initial Public Offering (“Ipo”). the Terms of the Sale by the Company of the Shares to Subscriber, and the Company and Subscriber’s Agreements Regarding the Shares, Are as Follows: 1. Purchase of Securities

from S-1/A 15 pages Registration Rights Agreement

from S-1 14 pages Form of Indemnity Agreement

from S-1 16 pages Subscription Agreement

from S-1 2 pages Innovatus Life Sciences Acquisition Sponsor, LLC 777 Third Avenue, 25th Floor New York, Ny 10017 Re: Administrative Services Agreement Ladies and Gentlemen

from S-1 7 pages Innovatus Life Sciences Acquisition Corp. 777 Third Avenue, 25th Floor New York, New York 10017 January 8, 2021

from S-1 4 pages Promissory Note

from S-1 7 pages Innovatus Life Sciences Acquisition Corp., a Delaware Corporation (The “Company”, “We” or “US”), Is Pleased to Accept the Offer Made by Innovatus Life Sciences Acquisition Sponsor, LLC, a Delaware Limited Liability Company (“Subscriber” or “You”), to Purchase 526,500 Shares (Or 579,000 Shares if the Over-Allotment Option in Connection With the Ipo (As Defined Below) Is Exercised in Full) (The “Shares”) of Class a Common Stock of the Company, $0.0001 Par Value Per Share (“Class a Common Stock”), at a Price of $10.00 Per Share Concurrently With the Company’s Initial Public Offering (“Ipo”). the Terms of the Sale by the Company of the Shares to Subscriber, and the Company and Subscriber’s Agreements Regarding the Shares, Are as Follows: 1. Purchase of Securities

from S-1 15 pages Registration Rights Agreement

from S-1 14 pages Investment Management Trust Agreement

from S-1 7 pages Innovatus Life Sciences Acquisition Corp. 777 Third Avenue, 25th Floor New York, New York 10017 Re: Initial Public Offering Ladies and Gentlemen

from DRS 7 pages Innovatus Life Sciences Acquisition Corp. 777 Third Avenue, 25th Floor New York, New York 10017 January 8, 2021

from DRS 4 pages Promissory Note